Revenues increased by 17 percent to 59.6 MSEK (51.1). Operating profit increased by 32 percent to 7.2 MSEK (5.5). Positive currency effects of 2.7 MSEK affected the result after financial items.
Revenues for Surgical Instruments increased by six percent to 30.1 MSEK (28.4). Profitability was affected by an unfavorable product and geographic market mix. Surgical Table-revenues grew by 30 percent to 29.5 MSEK (22.7). Sales have been particularly strong in EMEA with a growth of 47 percent.
The challenging environment, primarily with disturbances in supply chains, has affected Stille during the quarter. This has however not affected sales. The challenges are expected to continue going forward.
"The long waiting lists for elective surgery remains and must be addressed regardless. Stille contributes with premium products enabling maximal efficiency. With market leading brands, and cost-control, Stille stands well-prepared for the future", concludes Hanna Ernestam Wilkman.
MSEK | jul-sept 2022 | jul-sept 2021 | jan-sept 2022 | jan-sept 2021 | oct-sept 2021/22 | jan-dec 2021 |
Revenue | 59.6 | 51.1 | 184.5 | 127.5 | 244.1 | 187.1 |
Gross Profit Margin, % | 45.1 | 45.0 | 45.1 | 44.2 | 45.5 | 44.6 |
Operating Profit | 7.2 | 5.5 | 23.6 | 14.6 | 29.1 | 20.1 |
Operating Profit, % | 12.1 | 10.7 | 12.8 | 11.4 | 12.1 | 10.7 |
EBITDA | 9.4 | 7.4 | 30.4 | 19.3 | 38.0 | 26.8 |
Net Income | 6.5 | 3.4 | 19.6 | 10.2 | 25.6 | 16.1 |
Torshälla,
This information is such information that
For more information, please contact:
Hanna Ernestam Wilkman
CEO and President
+46 (0)72 402 10 88 | hanna.e.wilkman@stille.se
https://news.cision.com/stille/r/stille-ab--interim-report-q3-2022,c3655848
https://mb.cision.com/Main/1000/3655848/1644354.pdf
https://mb.cision.com/Public/1000/3655848/bfc3ae3ec1b661fb.pdf
(c) 2022 Cision. All rights reserved., source